About this trial
The goal of this observational study is to learn about the influence of extracellular water on volume status in adult sepsis patients presenting with hemodynamic instability. The main question it aims to answer is:
• Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients.
Patients with sepsis admitted to intensive care will receive standard care with the addition of measurement of extracellular water.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults with sepsis.
Disqualifiers
Pregnancy, other than sepsis known cause of shock.
Trial population
Adult patients admitted to an ICU in Uppsala with suspected or confirmed sepsis.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Phenotypes in sepsis - extracellular water for volume status characterization.
Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients during the first 72 hours?
Sponsors and contacts
Click on the lead sponsor to view all of their trials.